1. A143 SAFETY OF BIOLOGICAL THERAPIES IN ELDERLY IBD: A SYSTEMATIC REVIEW. (21st February 2022) Authors: Golovics, P; Drügg Hahn, G; Wetwittayakhlang, P; Wild, G; Afif, W; Bitton, A; Bessissow, T; Lakatos, P L Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A180 CLINICAL OUTCOMES OF COVID-19 AND IMPACT ON DISEASE COURSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. (21st February 2022) Authors: Wetwittayakhlang, P; Albader, F; Golovics, P; Drügg Hahn, G; Bessissow, T; Bitton, A; Afif, W; Wild, G; Lakatos, P L Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP25 Clinical outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease. (21st January 2022) Authors: Wetwittayakhlang, P; Albader, F; Golovics, P; Drügg Hahn, G; Bessissow, T; Bitton, A; Afif, W; Wild, G; Lakatos PhD, P L Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP63 Time Trends of Environmental and Socio-economical Factors in Patients with Inflammatory Bowel Disease over 40-year of Different Therapeutic Eras; results from a Population-based Cohort from Western Hungarian between 1977-2020, The Hygiene hypothesis revisited. (30th January 2023) Authors: Wetwittayakhlang, P; Gonczi, L; Lakatos, L; Golovics, P; Pandur, T; David, G; Erdelyi, Z; Szita, I; Lakatos, P L Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P309 Accuracy of PanMayo endoscopic score in predicting long-term disease outcomes in ulcerative colitis– a promising scoring system. (30th January 2023) Authors: Bacsur, P; Wetwittayakhlang, P; Resál, T; Rutka, M; Bessissow, T; Atif, W; Bálint, A; Fábián, A; Bor, R; Szepes, Z; Farkas, K; Lakatos, P L; Molnár, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P318 Safety of Biological Therapies in Elderly IBD: a Systematic Review and Meta-analysis. (21st January 2022) Authors: Drügg Hahn, G; Golovics, P; Wetwittayakhlang, P; Santa Maria, D; Britto, U; Wild, G; Afif, W; Bessissow, T; Bitton, A; Lakatos PhD, P L Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P321 Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn's Disease (SIMCHA study): final results from a prospective, open-label, single-arm study. (21st January 2022) Authors: Wetwittayakhlang, P; Golovics, P; Hahn, G; Bessissow, T; Afif, W; Wild, G; Bitton, A; Lakatos PhD, P L Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P417 Frequent Early Nocebo Complaints but Maintained Clinical Efficacy, Biomarker and Therapeutic drug levels following mandatory Biosimilar Switch in Patients with Inflammatory Bowel disease: Preliminary data from a Prospective Observational Cohort Study. (30th January 2023) Authors: Wetwittayakhlang, P; Karkout, K; Tselekouni, P; Aljabri, R; Bessissow, T; Afif, W; Wild, G; Bitton, A; Lakatos PhD, P L Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P451 Evaluating drug sustainability, efficacy and safety of biologic agents in elderly patients with Inflammatory Bowel Disease: a single center retrospective study. (21st January 2022) Authors: Golovics, P; LeBlanc, J F; Drügg Hahn, G; Wetwittayakhlang, P; Qatomah, A; Wang, A; Boodaghians, L; Liu, J; Al Ali, M; Wild, G E; Afif, W; Bitton, A; Lakatos, P L; Bessissow, T Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P829 The Burden of Colorectal Cancer in Patients with Ulcerative Colitis – Incidence and Risk factors from a Population-based Inception Cohort from Veszprem county, Western Hungary, from 1977–2020. (30th January 2023) Authors: Wetwittayakhlang, P; Golovics, P; Gonczi, L; Khoury, A; Kurti, Z; Pandur, T; David, G; Erdelyi, Z; Szita, I; Lakatos, L; Lakatos, P L Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i961 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗